ArticleFrontiers in oncology2025

LSM2 drives glioma progression through alternative splicing dysregulation: a multi-omics approach to identify a potential therapeutic target.

Cao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.